TransMedics (TMDX) Revenue Growth (3y) (2021 - 2026)
TransMedics (TMDX) Revenue Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 8.07% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 9.66% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 14.78% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.83% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 14.51% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 3.20% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 25.44% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 8.05% |
| 10 | TransMedics | 3.15 Bn | 2.67 Bn | 113.20 Mn | 53.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53.55% |
| Mar 31, 2026 | 61.16% |
| Dec 31, 2025 | 72.40% |
| Sep 30, 2025 | 77.58% |
| Jun 30, 2025 | 97.20% |
| Mar 31, 2025 | 108.31% |
| Dec 31, 2024 | 142.35% |
| Sep 30, 2024 | 172.58% |
| Jun 30, 2024 | 136.26% |
| Mar 31, 2024 | 133.20% |
| Dec 31, 2023 | 119.97% |
| Sep 30, 2023 | 102.73% |
| Jun 30, 2023 | 137.37% |
| Mar 31, 2023 | 76.71% |
| Dec 31, 2022 | 73.02% |
| Sep 30, 2022 | 52.76% |
| Jun 30, 2022 | 53.57% |
| Mar 31, 2022 | 50.31% |
| Dec 31, 2021 | 34.09% |
| Sep 30, 2021 | 9.96% |